OBJECTIVE: Validate Digital Cervicography as adjunctive cervical cancer screening test to VIA and Cytology. METHOD: Women (1292) were submitted to both cytological and VIA tests to obtain a sample of 301 positive VIA cases (23.3%) which have had the Digital Cervicography (DC) taken and evaluated. Just cases considered positive by DC (149/301 cases--49.5%) and/or positive Pap smear tests were referred to colposcopy and biopsy whenever indicated. RESULTS: Cervical smear was positive in 5.4%, including LGSIL (4%), HGSIL (1%) and one case of invasive cancer (0.4%), and 1.6% of ASCUS or AGUS). DC identified 81 positive cases (74 LGSIL; 5 HGSIL; 2 cancers). The sensitivity of cytology was 14.8%, and the DC was 100%. Corresponding specificities were 95.4% and 69.1%, respectively. The NPV and PPV for DC were 100% and 54.4%. CONCLUSION: DC increases sensitivity, specificity and positive predictive value of VIA, becoming a valid adjunctive screening test for cervical cancer in low resource settings.
OBJECTIVE: Validate Digital Cervicography as adjunctive cervical cancer screening test to VIA and Cytology. METHOD:Women (1292) were submitted to both cytological and VIA tests to obtain a sample of 301 positive VIA cases (23.3%) which have had the Digital Cervicography (DC) taken and evaluated. Just cases considered positive by DC (149/301 cases--49.5%) and/or positive Pap smear tests were referred to colposcopy and biopsy whenever indicated. RESULTS: Cervical smear was positive in 5.4%, including LGSIL (4%), HGSIL (1%) and one case of invasive cancer (0.4%), and 1.6% of ASCUS or AGUS). DC identified 81 positive cases (74 LGSIL; 5 HGSIL; 2 cancers). The sensitivity of cytology was 14.8%, and the DC was 100%. Corresponding specificities were 95.4% and 69.1%, respectively. The NPV and PPV for DC were 100% and 54.4%. CONCLUSION:DC increases sensitivity, specificity and positive predictive value of VIA, becoming a valid adjunctive screening test for cervical cancer in low resource settings.
Authors: Groesbeck P Parham; Mulindi H Mwanahamuntu; Krista S Pfaendler; Vikrant V Sahasrabuddhe; Daniel Myung; Gracilia Mkumba; Sharon Kapambwe; Bianca Mwanza; Carla Chibwesha; Michael L Hicks; Jeffrey S A Stringer Journal: J Low Genit Tract Dis Date: 2010-07 Impact factor: 1.925
Authors: Groesbeck P Parham; Mulindi H Mwanahamuntu; Vikrant V Sahasrabuddhe; Andrew O Westfall; Kristin E King; Carla Chibwesha; Krista S Pfaendler; Gracilia Mkumba; Victor Mudenda; Sharon Kapambwe; Sten H Vermund; Michael L Hicks; Jeffrey Sa Stringer; Benjamin H Chi Journal: HIV Ther Date: 2010
Authors: Ramin Asgary; Philip Baba Adongo; Adanna Nwameme; Helen V S Cole; Ernest Maya; Mengling Liu; Karen Yeates; Richard Adanu; Olugbenga Ogedegbe Journal: J Low Genit Tract Dis Date: 2016-07 Impact factor: 1.925
Authors: Mulindi H Mwanahamuntu; Vikrant V Sahasrabuddhe; Meridith Blevins; Sharon Kapambwe; Bryan E Shepherd; Carla Chibwesha; Krista S Pfaendler; Gracilia Mkumba; Belington Vwalika; Michael L Hicks; Sten H Vermund; Jeffrey Sa Stringer; Groesbeck P Parham Journal: PLoS One Date: 2013-09-18 Impact factor: 3.240
Authors: Cynthia Firnhaber; Lu Mao; Simon Levin; Mark Faesen; David A Lewis; Bridgette J Goeieman; Avril J Swarts; Ntombiyenkosi Rakhombe; Pam M Michelow; Sophie Williams; Jennifer S Smith Journal: J Low Genit Tract Dis Date: 2015-01 Impact factor: 1.925